z-logo
open-access-imgOpen Access
Thromboembolism and bleeding in patients with atrial fibrillation and stage 4 chronic kidney disease: impact of biomarkers
Author(s) -
Paweł T. Matusik,
Wiktor J Leśniak,
Zbigniew Heleniak,
Anetta Undas
Publication year - 2021
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.a2021.0088
Subject(s) - medicine , atrial fibrillation , renal function , kidney disease , hazard ratio , gastroenterology , prospective cohort study , cardiology , cystatin c , risk factor , confidence interval
Chronic kidney disease (CKD) is considered a risk factor for thromboembolic and bleeding events in patients with atrial fibrillation (AF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom